Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/09/1995 | WO1995029702A1 Texaphyrin solid-supports and devices |
11/09/1995 | WO1995029699A1 Vaccine for, diagnostic assay for and method of treating parasitic hemoflagellate protozoa |
11/09/1995 | WO1995029697A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
11/09/1995 | WO1995029686A1 Recombinant fibrin chains, fibrin and fibrin-homologs |
11/09/1995 | DE4441327C1 Embryonale Herzmuskelzellen, ihre Herstellung und ihre Verwendung Embryonic heart muscle cells, their preparation and their use |
11/09/1995 | DE4440118C1 Die Genexpression in coryneformen Bakterien regulierende DNA Gene expression in coryneform bacteria regulatory DNA |
11/09/1995 | DE4415743A1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them |
11/09/1995 | CA2690298A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases |
11/09/1995 | CA2190597A1 Genes regulating the response of zea mays to water deficit |
11/09/1995 | CA2189543A1 Thymidine kinase mutants |
11/09/1995 | CA2189542A1 Alkaline glucose oxidase |
11/09/1995 | CA2189438A1 Dna sequences |
11/09/1995 | CA2189428A1 Fabric cleaning compositions containing subtilisin bpn' variants |
11/09/1995 | CA2189067A1 Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line |
11/09/1995 | CA2189056A1 Improvements in or relating to disease-resistance of plants |
11/09/1995 | CA2189032A1 Enhancing the sensitivity of tumor cells to therapies |
11/09/1995 | CA2188647A1 Recombinant fibrin chains, fibrin and fibrin-homologs |
11/09/1995 | CA2187902A1 Morphogenic protein-specific cell surface receptors and uses therefor |
11/09/1995 | CA2186365A1 Neural receptor tyrosine kinase |
11/09/1995 | CA2165413A1 Methods for peptide synthesis and purification |
11/08/1995 | EP0681028A1 A gene expression vector using the gene expression regulating region of the ADP ribosylation factor |
11/08/1995 | EP0681027A2 Plasmid vector and its use for the production of heterologous proteins |
11/08/1995 | EP0681026A1 Recombinant mycobacterial vaccine |
11/08/1995 | EP0681025A1 Novel cloning host organisms |
11/08/1995 | EP0680969A2 Modified oligonucleotides, their preparation and their use |
11/08/1995 | EP0680765A1 Vaccine for nontypable haemophilus influenzae strain |
11/08/1995 | EP0680607A1 Assay method to rule out rupture of membranes in women at risk for imminent delivery |
11/08/1995 | EP0680605A1 Entrapment of nucleic acid sequencing template in sample mixtures by entangled polymer networks |
11/08/1995 | EP0680518A1 Detection of synthetic oligonucleotides extracted from body fluids or tissues. |
11/08/1995 | EP0680517A1 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound |
11/08/1995 | EP0680516A1 High resolution dna sequencing method using low viscosity medium |
11/08/1995 | EP0680514A1 Nematode-resistant transgenic plants |
11/08/1995 | EP0680513A1 Lysosomal targeting of immunogens |
11/08/1995 | EP0680512A1 Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom |
11/08/1995 | EP0680511A1 Acetyl-coa-carboxylase-gene |
11/08/1995 | EP0680495A1 Structured copolymers used as absorbents, gels and carriers of metal ions |
11/08/1995 | EP0680489A1 Foldback triplex-forming oligonucleotides |
11/08/1995 | EP0680380A1 Methods of analysis/separation |
11/08/1995 | EP0680335A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
11/08/1995 | EP0680331A1 Recombinant virus immunotherapy |
11/08/1995 | EP0680330A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
11/08/1995 | EP0680316A1 Novel parasitic helminth proteins |
11/08/1995 | EP0680315A1 Method for preparing a viral aerosol |
11/08/1995 | EP0680258A1 Aprotinin and synergistic combinations thereof with lectins as larvicides against insect pests of agronomic crops, harvested material thereof, and products obtained from the harvested material |
11/08/1995 | EP0539490B1 Library screening method |
11/08/1995 | EP0457901B1 Free fatty acid determination |
11/08/1995 | EP0425572B1 Uses of viral enzymes |
11/08/1995 | EP0419574B1 Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same |
11/08/1995 | EP0393051B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES |
11/08/1995 | EP0373181B1 Novel coenzyme independent l-sorbosone dehydrogenase |
11/08/1995 | CN1111455A Peptide inhibitors of mitogenesis and motorgenesis |
11/08/1995 | CN1111284A Recombination vaccinia virus for expression of measles virus L4 strain hemagglutinin and fusion protein gene |
11/07/1995 | US5464945 Oligonucleotide probes specific for the human alpha satellite locus |
11/07/1995 | US5464944 Synthetic antifungal peptides |
11/07/1995 | US5464943 Fibroblast growth factor |
11/07/1995 | US5464939 Highly purified protein, production and use thereof |
11/07/1995 | US5464937 Type II Interleukin-1 receptors |
11/07/1995 | US5464935 Peptide inhibitors of selectin binding |
11/07/1995 | US5464933 Synthetic peptide inhibitors of HIV transmission |
11/07/1995 | US5464823 Mammalian antibiotic peptides |
11/07/1995 | US5464822 Polypeptides and polypeptide analogues |
11/07/1995 | US5464770 Artificial sweeteners |
11/07/1995 | US5464765 Needles for cell transformation of monocotyledons |
11/07/1995 | US5464764 Method for enriching transformed murine embryonic stem cell containing modification in target DNA sequence in genome of cell |
11/07/1995 | US5464763 Infection with Agrobacterium, plasmids with and without T-regions and vir-regions of tumor inducing plasmid |
11/07/1995 | US5464759 Sequential oligonucleotide syntheses using immunoaffinity techniques |
11/07/1995 | US5464758 Polynucleotide molecule codes for eukarotic proteins |
11/07/1995 | US5464757 Corticotropin releasing factor, genetic engineering |
11/07/1995 | US5464756 Processes and compositions for the isolation of human relaxin |
11/07/1995 | US5464747 Oxidation-resistant muteins of β-galactosidase fragments |
11/07/1995 | US5464745 Protein ligand binding region mapping system |
11/07/1995 | US5464743 Detecting yeast |
11/07/1995 | CA1337518C Monoclonal antibodies against tnf-, hybridomas producing them and method for the purification of tnf- |
11/03/1995 | CA2148312A1 Modified oligonucleotides, their preparation and their use |
11/02/1995 | WO1995029404A1 Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation |
11/02/1995 | WO1995029260A2 Detection of fungal pathogens using the polymerase chain reaction |
11/02/1995 | WO1995029259A1 Method and means for detecting and treating disorders in the blood coagulation cascade |
11/02/1995 | WO1995029258A1 Nucleic acid mutation assays |
11/02/1995 | WO1995029257A2 Apolipoprotein e polymorphism and treatment of alzheimer's disease |
11/02/1995 | WO1995029256A1 Chondroitinases i and ii, methods of preparation, and use thereof |
11/02/1995 | WO1995029254A1 An in vivo gene expression system |
11/02/1995 | WO1995029253A1 Dna encoding cephamycin biosynthesis late enzymes |
11/02/1995 | WO1995029251A1 Detection of mutation by resolvase cleavage |
11/02/1995 | WO1995029248A1 HERPES VIRUS TRANSFORMED TO EXPRESS gD $i(IN VITRO) |
11/02/1995 | WO1995029247A1 Regulatory element conferring tapetum specificity |
11/02/1995 | WO1995029246A1 Plant gene specifying acetyl coenzyme a carboxylase and transformed plants containing same |
11/02/1995 | WO1995029244A1 Method to increase regulatory molecule production |
11/02/1995 | WO1995029243A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils |
11/02/1995 | WO1995029242A1 Angiostatin and method of use for inhibition of angiogenesis |
11/02/1995 | WO1995029241A2 Ribozymes with product ejection by strand displacement |
11/02/1995 | WO1995029240A1 Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines |
11/02/1995 | WO1995029239A2 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production |
11/02/1995 | WO1995029238A1 Genetic sequences conferring disease resistance in plants and uses therefor |
11/02/1995 | WO1995029237A1 Cardiotrophin and uses therefor |
11/02/1995 | WO1995029236A2 Lymphocyte activation antigens and antibodies thereto |
11/02/1995 | WO1995029235A1 Spider neurotoxins and method of producing the same |
11/02/1995 | WO1995029234A1 Human gamma 3 gaba-a receptor subunit and stably co-transfected cell lines |
11/02/1995 | WO1995029233A1 ISOLATED NUCLEIC ACID MOLECULE CODING FOR FIBROBLAST ACTIVATION PROTEIN α AND USES THEREOF |
11/02/1995 | WO1995029193A2 Melanoma antigens |
11/02/1995 | WO1995029188A1 Human sperm diagnostic |